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Chemical-chemical profiling, as described in Farha and Brown (2010), delivers all the power of chemical-
genomic profiling while untethering researchers from model systems and thereby enabling us to pursue
cell-based drug target identification in almost any organism.Figure 1. Comparison of Genetic, Chemical-Genetic, and Chemical-Chemical
Interactions
(A) Two interacting gene products are presented as blue and green with the phenotype presented
below. In genetic interactions, two genes are inactivated via targeted deletion and the resultant
double mutant assessed for viability (Tong et al., 2004). In chemical-genetic interactions, one
gene product is inactivated via gene deletion and the other is inactivated by chemical inhibition
(Parsons et al., 2006). In a chemical-chemical interaction, the activities of two independent com-
pounds are synergistic. A library of unknown compounds can be screened against a suite of known
compounds of diverse targets and modes-of-action to create a chemical-chemical profile of inter-
actions (B) (red indicates a synergistic interaction), and used to predict the target process of
unknown agents. Here, known compounds on the x axis are clustered based on mode of action,
and the y axis shows clustering of unknowns with similar profiles. This example is specific to anti-
fungal agents.Chemical genomics approaches enable
us to explore the targets of bioactive com-
pounds and usually involve screening via
functional genomic resources, such as
genome-wide gene deletion or gene
overexpression libraries, for chemical
response. In general, chemical genomics
requires a genetically tractable model
organism because they facilitate the
development of the relevant functional
genomic resources. Consequently, the
field of chemical genomics has largely
been developed with the exclusion of
undomesticated but important organ-
isms, such as our own pathogens. How-
ever, here in this issue, Farha and Brown
(2010) describe a very simple but new
and systematic approach for target
identification in cell-based systems and,
significantly, one that does not depend
on a specialized model organism.
A major advantage of a model system
is that a genome-wide set of genetic
interaction profiles serves as a key for
interpreting chemical-genomic profiles,
which enables us to link previously un-
characterized compounds to their cellular
targets (Costanzo et al., 2010). Building
upon drug synergies, chemical-chemical
profiling uses the same concept of chem-
ical-genomic profiling to probe for interac-
tions between unknown compounds and
their target pathways; however, genes
are reversibly inhibited using chemicals
of a known target and mode-of-action
(MOA), rather than deletion to render a
gene nonfunctional (Figure 1A). With a
sufficient collection of diverse reference
drugs of known action and target, one
can screen for synergistic (or antagonistic)
interactions and create a profile muchChemistry & Biology 17, August 27, 2010 ª2010 Elsevier Ltd All rights reserved 789
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action profile that leads to a prediction of
an unknown compound’s MOA and target
(Figure 1B).
Using chemical combinations to probe
genetic networks is an area of active
research, and has potential not only in
identifying genetic interactions, but also
in developing polytherapies for drug-re-
sistant pathogens using approved drugs
(Lehar et al., 2007, 2008; Jansen et al.,
2009). The step taken by Farha andBrown
(2010) was to use the phenomena to
systematically screen a number of novel
compounds to predict MOA. They de-
scribe a synergy screen of 186 unknown
bioactive compounds against 14 well-
known bioactive compounds, identifying
255 synergistic combinations. The
authors then used the chemical-chemical
interaction profile to predict the mode-of-
action of two unknown bioactive com-
pounds. This is the first report that uses
simple synergy screening to derive pre-
dictive information on unknown com-
pounds. While the predicted targets
presented require detailed validation via
more traditional biochemical and bio-
physical methods, this method may sig-
nificantly shorten the steps from hit to
putative target in alternative systems.
Because a deletion collection is not
required, there is no prerequisite model790 Chemistry & Biology 17, August 27, 2010system, enabling chemical-chemical pro-
filing of unknown compounds with almost
any microorganism. Moreover, while the
authors have demonstrated their chemi-
cal-chemical profiling concept using
E. coli, it can be extended to eukaryotes
as well. Farha and Brown (2010) lay the
groundwork for further developing chem-
ical-chemical profiling, but this well-
informed approach is limited by a small
number of compounds with specifically-
defined targets, which anchor the profiles
in a mechanistic understanding.
Nevertheless, the power of chemical-
chemical profiling lies in its simplicity
and broad application. As long as you
have a set of compounds with known
and diverse targets in an organism, you
can test for synergies and create a profile
for target prediction in nearly any system.
Moreover, asmore screensover a broader
taxonomic range and chemical space are
conducted, the chemical-chemical pro-
files will increase in complexity and
subsequent information. These data will
greatly benefit from a centralized data-
base of chemical-chemical as well as
chemical-genomic and genetic interac-
tions. The next decade of chemical geno-
mics will see an exponential increase in
data generation and target identification,
which will undoubtedly lead to novel
chemical probes and accentuate theª2010 Elsevier Ltd All rights reservedpower of this approach. With the sys-
tem-independent tools as described in
Farha and Brown (2010), we can now start
to explore broader evolutionary questions
of genetic networks, or screen novel
compounds libraries against emerging or
resistant infectious pathogens, expand-
ing the field beyond the awesome power
of our favorite model organisms.REFERENCES
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